Nilca, Vilma .

HRN: 27-29-10  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/14/2025
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
11/14/2025
11/21/2025
PO
5.3ml
BID
PCAP-B
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines